Early Outpatient Treatment With Remdesivir in Patients at High Risk for Severe COVID-19: A Prospective Cohort Study
Sign Up to like & getrecommendations! Published in 2022 at "Open Forum Infectious Diseases"
DOI: 10.1093/ofid/ofac502
Abstract: Abstract Background Early treatment of coronavirus disease 2019 (COVID-19) with remdesivir in high-risk patients, including those with immunosuppression of different causes, has not been evaluated. The objective of this study was to assess the clinical… read more here.
Keywords: remdesivir; prospective cohort; high risk; treatment remdesivir ... See more keywords
Efficacy and safety of acetylcysteine for the prevention of liver injury in COVID-19 intensive care unit patients under treatment with remdesivir
Sign Up to like & getrecommendations! Published in 2022 at "Gastroenterology and Hepatology From Bed to Bench"
DOI: 10.22037/ghfbb.v15i3.2565
Abstract: Aim: The present double-blinded placebo-controlled randomized clinical trial evaluated prophylactic use of acetylcysteine for the prevention of liver injury in patients with severe COVID-19 pneumonia under treatment with remdesivir. Background: Liver injury is reportedly common… read more here.
Keywords: acetylcysteine; liver injury; treatment remdesivir; acetylcysteine prevention ... See more keywords